Get the Stockscreener App
6.30
7.49%
-0.51
After Hours:
6.30
Compass Pathways Plc Adr stock is traded at $6.30, with a volume of 849.10K.
It is down -7.49% in the last 24 hours and down -15.78% over the past month.
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
See More
Previous Close:
$6.81
Open:
$6.75
24h Volume:
849.10K
Relative Volume:
1.92
Market Cap:
$441.10M
Revenue:
-
Net Income/Loss:
$-118.46M
P/E Ratio:
-2.6809
EPS:
-2.35
Net Cash Flow:
$-97.44M
1W Performance:
-9.74%
1M Performance:
-15.78%
6M Performance:
-24.28%
1Y Performance:
-14.86%
1-Day Range:
$6.15
$6.82
1-Week Range:
$6.15
$7.09
52-Week Range:
$5.01
$12.75
Compass Pathways Plc Adr Stock (CMPS) Company Profile
Name
Compass Pathways Plc Adr
Sector
Industry
Phone
1-716-676-6461
Address
3RD FLOOR, 1 ASHLEY ROAD, CHESIRE
Compass Pathways Plc Adr Stock (CMPS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Nov-21-22 | Resumed | Berenberg | Buy |
| Nov-01-22 | Initiated | Loop Capital | Buy |
| Oct-29-21 | Initiated | Oppenheimer | Outperform |
| Jul-13-21 | Initiated | Citigroup | Buy |
| Jun-28-21 | Initiated | Maxim Group | Buy |
| May-11-21 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-01-21 | Initiated | ROTH Capital | Buy |
| Oct-14-20 | Initiated | H.C. Wainwright | Buy |
| Oct-13-20 | Initiated | Berenberg | Buy |
| Oct-13-20 | Initiated | Canaccord Genuity | Buy |
| Oct-13-20 | Initiated | Cowen | Outperform |
| Oct-13-20 | Initiated | Evercore ISI | Outperform |
View All
Compass Pathways Plc Adr Stock (CMPS) Latest News
Atai Life Sciences executives sell shares valued at $16 million - Investing.com India
Atai Life Sciences executives sell shares valued at $16 million - Investing.com
Market Resilience: Compass Pathways Plc ADR (CMPS) Finishes Weak at 6.96, Down -0.29 - The Dwinnex
Recent Insider Activity Could Benefit Compass Pathways Plc ADR (CMPS) - Knox Daily
Examining the Potential Price Growth of Lindblad Expeditions Holdings Inc (LIND) - Knox Daily
Checking in on Terreno Realty Corp (TRNO) after recent insiders movement - Knox Daily
Compass Pathways Plc ADR (CMPS) is looking forward to a strong quarter - SETE News
Compass Pathways Plc ADR [CMPS] Records 50-Day SMA of $7.01 - Knox Daily
Compass Pathways Plc ADR Inc. (CMPS) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
Ratios Uncovered: Breaking Down Compass Pathways Plc ADR (CMPS)’s Trailing Twelve Months Metrics - The Dwinnex
Can you now get a good deal on Compass Pathways Plc ADR’s shares? - US Post News
Keeping an Eye on BrightSpring Health Services Inc (BTSG) After Insider Trading Activity - Knox Daily
Compass Pathways Plc ADR [CMPS] Stock sold by Insider Malievskaia Ekaterina for $70379.0 - Knox Daily
Analyzing Southern Missouri Bancorp, Inc. (SMBC) After Recent Trading Activity - Knox Daily
SILO Pharma Inc [SILO] Investment Guide: What You Need to Know - Knox Daily
Selling Buzz: Compass Pathways Plc ADR [CMPS] 10% Owner Malievskaia Ekaterina sells 8,900 shares of the company – Knox Daily - Knox Daily
Financial Metrics Exploration: Understanding Compass Pathways Plc ADR (CMPS) Through Ratios - The Dwinnex
How does Compass Pathways Plc ADR (CMPS) change from a tortoise to a hare? - SETE News
Compass Pathways to participate in three investor conferences in September - GlobeNewswire Inc.
A year in review: Compass Pathways Plc ADR (CMPS)’s performance in the last year - US Post News
Recent Insider Activity Suggests Potential Gains for Compass Pathways Plc ADR (CMPS) - Knox Daily
Compass Pathways Plc ADR (CMPS) gets rating Initiated from RBC Capital Mkts - Knox Daily
Jackson Financial Inc (JXN) expanding its growth trajectory ahead - SETE News
Financial Snapshot: Analyzing Compass Pathways Plc ADR (CMPS)’s Key Ratio Metrics - The Dwinnex
A History of Outperforming Analyst Forecasts and Beating the Odds: Informatica Inc (INFA) - SETE News
Are Compass Pathways Plc ADR (CMPS) shares a good deal now? - US Post News
Li Auto Inc. Sponsored ADR (LI) Advances While Market Declines: Some Information for Investors - Yahoo Finance
4 Psychedelic Stocks to Consider as Clinical Trials Heat up - Investing.com
Compass Pathways Plc ADR (CMPS) shows promising results - US Post News
XPeng Inc. Sponsored ADR (XPEV) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Earnings call: COMPASS Pathways Reports Q2 2024 Progress on Psilocybin Trials - Investing.com India
Earnings call: COMPASS Pathways Reports Q2 2024 Progress on Psilocybin Trials - Investing.com
Compass Pathways Plc ADR (CMPS) Stock: Navigating a Year of Volatility - The InvestChronicle
Trading Day Triumph: Compass Pathways Plc ADR (CMPS) Ends at 6.88, a -9.83 Surge/Plunge - The Dwinnex
CNO Stock Sees Surge of Approximately 9.89% in Last Five Days - Knox Daily
1 Biotech Stock Under $10 That Could Surge 420% - Barchart
Insider Sale Alert: Compass Pathways Plc ADR [CMPS] – Is it Time to sell? - Knox Daily
MAN GRP PLC/ADR (OTCMKTS:MNGPY) Shares Cross Above 200-Day Moving Average of $1.79 - Defense World
Why the Market Dipped But XPeng Inc. Sponsored ADR (XPEV) Gained Today - Yahoo Finance
Investing in Compass Pathways Plc ADR (CMPS) might be an excellent idea, but the stock is currently overvalued/undervalued – US Post News - US Post News
Compass Pathways initiated at 'Outperform' by RBC, cites $2.3B revenue potential - Investing.com
Sea Limited Sponsored ADR (SE) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
A better buy-in window may exist right now for Compass Pathways Plc ADR (CMPS) - SETE News
The Attractiveness of Investing In Compass Pathways Plc ADR (CMPS) is Growing - Knox Daily
Compass Pathways Plc ADR [CMPS] Investment Appeal on the Rise - Knox Daily
Horizons PSYK ETF Review: The World’s First Psychedelics Fund (Sep 2024) - Wealth Awesome
Compass Pathways Plc ADR [CMPS] Shares Rise 7.30 on Wednesday – Knox Daily - Knox Daily
Compass Pathways appoints new Chief Commercial Officer By Investing.com - Investing.com India
Compass Pathways appoints new Chief Commercial Officer - Investing.com
Rivian stock retains Sell rating amid VW investment By Investing.com - Investing.com India
Compass Pathways appoints new Chief Commercial Officer By Investing.com - Investing.com UK
Compass Pathways Plc Adr Stock (CMPS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.21%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):